Osmotica Pharmaceutical recalls
FDA enforcement reports naming Osmotica Pharmaceutical Corp as the recalling firm.
- Recall reports
- 4
- Class I (serious)
- 0
- Most recent report
- Mar 14, 2018
- Mar 14, 2018Methylphenidate Hydrochloride Extended-release Tablets, USP, 36 mg, 100-count bottle, R…Drug · Osmotica Pharmaceutical CorpSubpotent Drug:100-count product bottle labeled as Methylphenidate HCL ER Tablets 36 mg found to contain 1 27 mg Methylphenidate HCL ER Tablet.Class III
- Dec 27, 2017Methylphenidate Hydrochloride Extended-release Tablets, USP 27 mg, 100-count bottles,…Drug · Osmotica Pharmaceutical CorpSubpotent DrugClass III
- Dec 27, 2017Methylphenidate Hydrochloride Extended-release Tablets, USP 54 mg, 100-count bottles, R…Drug · Osmotica Pharmaceutical CorpSubpotent DrugClass III
- Oct 9, 2013Venlafaxine (Venlafaxine Hydrochloride) extended release Tablets, 225 mg, packaged in a…Drug · Osmotica Pharmaceutical CorpFailed Dissolution Specification:12 hour time point at 18 months of product shelf life.Class III